After the recent underperformance due to the FDA threat regarding flavoured cigars, the strong set of first quarter figures should support the stock. The group is efficiently pursuing the development of ZYN in the US, and that’s all that is required at the moment.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
ZYN continues its conquest of the US
- Published:
06 May 2021 -
Author:
Laura Parisot -
Pages:
2
After the recent underperformance due to the FDA threat regarding flavoured cigars, the strong set of first quarter figures should support the stock. The group is efficiently pursuing the development of ZYN in the US, and that’s all that is required at the moment.